DNM1L and Alzheimer disease: A recent study has shown enhanced fission protein DRP1 and FIS1 expressions in AD patients, which strongly suggests the induction of mitochondrial fragmentation, while fusion protein MFN2, and OPA1 expression levels are reduced [55].